ClinicalTrials.gg
Not yet recruitingNCT05844319Updated May 6, 2023

Pain Management In Knee Osteoarthritis

An interventional study of tele-education in Osteoarthritis, Knee Osteoarthritis and Pain, Chronic, sponsored by Istanbul University. Not yet recruiting at 1 site in Turkey. Open to participants aged 45 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-05-06.

Primary conditionOsteoarthritis, KneeRegistry: OsteoarthritisReclassifiedWhy we changed it
Registry
Osteoarthritis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Osteoarthritis, Knee
Why
  1. The study's listed conditions name Osteoarthritis, Knee, a narrower term within Osteoarthritis.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Istanbul University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 7 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
45 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Osteoarthritis, Knee by Istanbul University — 3 open to participants now, 3 under way, none of them phase 3. Osteoarthritis, Knee · Istanbul University.

Started
2023
with 3 others
No phase
9 of 11
2 open now
Registered
5th of 11
by date

Among the 11 studies in Osteoarthritis, Knee by Istanbul University, this one is one of 4 that started in 2023, is one of 9 with no phase, and was the 5th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

3 of the 11 studies in Osteoarthritis, Knee by Istanbul University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 45 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Osteoarthritis, Knee by Istanbul University, or all of them as a file.
02

Study summary

In this study, it was aimed to investigate the effect of pain management education in individuals with knee osteoarthritis with chronic pain.

Read the detailed description

Knee osteoarthritis (OA), also known as degenerative joint disease of the knee, is typically the result of wear and tear and progressive loss of joint cartilage. Knee osteoarthritis can be divided into two types, primary and secondary. It is most common in the elderly. The intensity of clinical symptoms can vary from person to person. However, they typically become more severe, more frequent, and more debilitating over time. The rate of progression also varies with each individual. People suffering from knee osteoarthritis complain of limited range of motion and pain when they move their knee or start walking. In advanced disease, they may complain of nocturnal or persistent knee pain and the functionality of the joint is severely impaired. Knee osteoarthritis treatment begins with non-surgical (conservative) treatment methods. Non-surgical treatment includes patient education, lifestyle modification, and the use of orthotic devices. It has been shown that untreated pain in the elderly can have a general impact on their quality of life and lead to depression, anxiety, social isolation, cognitive impairment, inactivity, and sleep disorders. The aim of our project is to provide training for patients diagnosed with knee osteoarthritis with chronic pain to be able to control their pain with self-management and to perform activities of daily living more easily. Appropriate knowledge and awareness can improve their quality of life. Performing safe and accurate pain management practices in the elderly can improve their performance, quality of life, increase their comfort and reduce their care costs. In this study, it was aimed to investigate the effect of pain management education in individuals with knee osteoarthritis with chronic pain.

03

Conditions studied

  • Osteoarthritis
  • Knee Osteoarthritis
  • Pain, Chronic

Browse trials for

Keywords

  • Osteoarthritis
  • Pain Management
  • Activities of Daily Living
  • Quality of Life
  • Tele-education
04

In context

Osteoarthritis, Knee Reclassified

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's planned enrollment of 25 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Istanbul University is the lead sponsor of 514 studies on the registry; 78 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Compared within Osteoarthritis, Knee, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Osteoarthritis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
45 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • To be diagnosed with knee OA according to the criteria of the American College of Rheumatology (ACR)
  • Be between 45 and 75 years old
  • Stage 2-3 according to Kellgren Lawrence (K-L) in the radiological examination

Exclusion criteria

Exclusion Criteria:

  • Having active synovitis
  • Receiving physical therapy in the last 6 months
  • People with neurological problems that affect walking
  • Those with arthritis in the ankle and hip joint
  • Those with serious respiratory, central, peripheral, vascular and uncontrolled metabolic problems that will prevent exercise.
  • Have had surgery on the lower extremity in the past
  • Intra-articular injections in the last 6 months
  • Use of psychoactive drugs
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    intervention

    Following the completion of the evaluations of the cases, the following 6-step program will be applied to cope with the pain: 1. Informative education about the disease 2. Teaching relaxation positions for pain management 3. Relaxation exercises with breathing exercises 4. Training on ergonomic approaches in daily life (correct sitting, lying, working, carrying, etc.) 5. Education of principles of joint protection 6. Creating and training a personalized physical activity and exercise plan

    Other: tele-education

Interventions

  • Othertele-education

    The treatment of the patients will be carried out by tele-education method.

07

What researchers measure

Primary outcomes

  1. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)

    We will use the Knee Injury and Osteoarthritis Outcome Score (KOOS) in order not to exceed the pain and daily life span of our patients. It is a scale that evaluates the functional status and groups related to knee injuries and knee osteoarthritis. Other definition of pain has 5 subgroups, including functional status related to daily life span, functional status in sports and leisure activities, and sequence-related quality of life. It consists of 42 questions lasting approximately 10 minutes. Each subscale is scored between 0-100. 0 indicates serious problem, 100 indicates no problem. A score of 10 and above indicates that it changes clinically.

    Time frame: on the first day and eighth week change

Secondary outcomes

  1. The McGill Pain Questionnaire

    We will use the McGill Pain Questionnaire to evaluate the pain status of our patients. The McGill Pain Questionnaire is a chart with descriptive words about pain. Words are normally divided into four main categories: sensory, emotional, evaluative, and miscellaneous. Within these categories are specific subcategories that contain words used to describe the intensity of a particular sensation or emotional response. Following a particular method, patients choose the most appropriate words from each category to describe their pain to their doctor as precisely and precisely as possible. This can lead to better pain management and, in some cases, better and faster diagnosis. The most common version has 20 subcategories of descriptive words.

    Time frame: on the first day and eighth week change

  2. Short Form-12

    Similar to SF-36, SF-12 has physical functionality (2 items), physical role (2 items), body pain (1 item), general health (1 item), energy (1 item), social functionality (1 item) It consists of 8 sub-dimensions and 12 items: emotional role (2 items) and mental health (2 items). Items related to physical and emotional role were answered as dichotomy (yes or no), while other items had Likert type options ranging between 3 and 6.

    Time frame: on the first day and eighth week change

08

Study locations

1 site
  • Tugba Civi Karaaslan
    Istanbul, Buyukcekmece, Turkey
    • TUGBA CIVI KARAASLAN, PhD · Contacttugba.civi@istanbul.edu.tr
    • MEHMET YAZGAN, BSc · Sub investigator
    • MELIKE KARAVUL, BSc · Sub investigator
    • HUSEYIN BAYBAS, BSc · Sub investigator
    • ELA TARAKCI, Prof · Principal investigator
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2023; primary completion for Apr 2024, 11 months later.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 11 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 25, 2023
First posted
May 6, 2023
StartEst.
May 1, 2023
Primary completionEst.
Apr 1, 2024
CompletionEst.
May 1, 2024
Last update
May 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05844319
Responsible party
Tugba Civi Karaaslan (Research Assistant, Istanbul University - Cerrahpasa) — Principal investigator
First posted
May 6, 2023
Start date
May 1, 2023 (estimated)
Primary completion
Apr 1, 2024 (estimated)
Completion
May 1, 2024 (estimated)
Last update
May 6, 2023

Study contacts

TUGBA CIVI KARAASLAN, PhD
Contact
tugba.civi@istanbul.edu.tr
05343855606
MEHMET YAZGAN, BSc
study director · Istanbul University - Cerrahpasa
MELIKE KARAVUL, BSc
principal investigator · Istanbul University - Cerrahpasa
HUSEYIN BAYBAS, BSc
principal investigator · Istanbul University - Cerrahpasa
ELA TARAKCI, Prof
study chair · Istanbul University - Cerrahpasa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion